Kbc Group Nv Biotechnology

Kbc Group Nv

$36.3 Billion
Q4 2024

Stock List

Stock	Market Cap.	Holding Value (Reported)	# of Shares.	Last Trade	Trade History
LGND Ligand Pharmaceuticals Inc	$1.77B	$97,000 0.0% of portfolio	904	Q4 2024 Added 49.67%
FOLD Amicus Therapeutics, Inc.	$1.88B	$96,000 0.0% of portfolio	10,154	Q4 2024 Added 44.36%
SWTX Spring Works Therapeutics, Inc.	$2.31B	$95,000 0.0% of portfolio	2,634	Q4 2024 Added 59.06%
CLDX Celldex Therapeutics, Inc.	$886M	$94,000 0.0% of portfolio	3,728	Q4 2024 Added 79.14%
ACAD Acadia Pharmaceuticals Inc	$2.33B	$93,000 0.0% of portfolio	5,093	Q4 2024 Added 67.04%
SNDX Syndax Pharmaceuticals Inc	$675M	$92,000 0.0% of portfolio	6,954	Q4 2024 Added 104.83%
IOVA Iovance Biotherapeutics, Inc.	$486M	$91,000 0.0% of portfolio	12,303	Q4 2024 Added 105.67%
XNCR Xencor Inc	$633M	$90,000 0.0% of portfolio	3,936	Q4 2024 Added 26.03%
KYMR Kymera Therapeutics, Inc.	$1.49B	$87,000 0.0% of portfolio	2,151	Q4 2024 Added 53.75%
AGIO Agios Pharmaceuticals, Inc.	$1.5B	$86,000 0.0% of portfolio	2,615	Q4 2024 Added 30.49%
GERN Geron Corp	$510M	$86,000 0.0% of portfolio	24,414	Q4 2024 Added 45.13%
RXRX Recursion Pharmaceuticals, Inc.	$976M	$83,000 0.0% of portfolio	12,307	Q4 2024 Added 61.89%
PTGX Protagonist Therapeutics, Inc	$2.25B	$81,000 0.0% of portfolio	2,093	Q4 2024 Added 54.35%
BCRX Biocryst Pharmaceuticals Inc	$1.4B	$77,000 0.0% of portfolio	10,198	Q4 2024 Added 80.14%
IMVT Immunovant, Inc.	$3.55B	$77,000 0.0% of portfolio	3,099	Q4 2024 Added 60.07%
DYN Dyne Therapeutics, Inc.	$483M	$74,000 0.0% of portfolio	3,135	Q4 2024 Added 45.34%
INVA Innoviva, Inc.	$1.27B	$71,000 0.0% of portfolio	4,100	Q4 2024 Added 73.95%
NTLA Intellia Therapeutics, Inc.	$602M	$71,000 0.0% of portfolio	6,093	Q4 2024 Added 62.35%
ARDX Ardelyx, Inc.	$722M	$69,000 0.0% of portfolio	13,706	Q4 2024 Added 101.83%
RCKT Rocket Pharmaceuticals, Inc.	$543M	$69,000 0.0% of portfolio	5,475	Q4 2024 Added 159.6%
WVE Wave Life Sciences Ltd.	$531M	$67,000 0.0% of portfolio	5,440	Q4 2024 New
VIR Vir Biotechnology, Inc.	$744M	$66,000 0.0% of portfolio	8,970	Q4 2024 Added 136.49%
NVAX Novavax Inc	$470M	$64,000 0.0% of portfolio	7,954	Q4 2024 Added 97.03%
HRMY Harmony Biosciences Holdings, Inc.	$1.69B	$63,000 0.0% of portfolio	1,844	Q4 2024 Added 79.9%
ASND Ascendis Pharma A/S	$8.99B	$57,000 0.0% of portfolio	411	Q3 2024 New
ARVN Arvinas, Inc.	$466M	$55,000 0.0% of portfolio	2,885	Q4 2024 Added 76.99%
ADPT Adaptive Biotechnologies Corp	$976M	$50,000 0.0% of portfolio	8,378	Q4 2024 New
KROS Keros Therapeutics, Inc.	$368M	$26,000 0.0% of portfolio	1,622	Q4 2024 Added 28.42%
OLMA Olema Pharmaceuticals, Inc.	$192M	$24,000 0.0% of portfolio	4,075	Q4 2024 New
SAVA Cassava Sciences Inc	$58.5M	$5,000 0.0% of portfolio	1,944	Q3 2024 New

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Kbc Group Nv, based on Form 13F filings with the SEC.

News

Stay updated on Kbc Group Nv with notifications on news.